Transition to LIVE (Long-term In Home Ventilation Engagement) Study (TTLive)

January 30, 2026 updated by: Reshma Amin, The Hospital for Sick Children

A Virtual Transition Intervention for Children and Adults Transitioning to Home Ventilation in Ontario: A Pragmatic Randomized Controlled Trial

The rising prevalence of ventilator assisted individuals (VAIs) who depend on Home Mechanical Ventilation (HMV) is an escalating public health challenge with important social and economic implications. VAIs are high cost users of the healthcare system, requiring competent healthcare and family caregivers for successful transition to HMV. The TTLive Study will evaluate the effect of a virtual transition intervention delivered through a virtual care platform, compared to usual care on emergent healthcare utilization, caregiver burden, health cost-effectiveness including cost of family caregiver time, and efficiency of clinical encounters for individuals newly transitioning to HMV.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Ventilator Assisted Individuals (VAIs) on HMVs are an ideal population for a virtual care platform that offers a comprehensive bundle of virtual care solutions, sophisticated enough for the complex care demands of this population. A first complex care demand is the challenging clinical follow ups that impose significant financial and medical costs associated with travel to healthcare appointments, and which can predispose these patients to adverse events during travel periods due to an inability to maintain access to some vital technology such as suctioning.

A second complex care demand is the multiple transitions in care as some VAIs on HMVs move between and within healthcare sectors due to changing health status or care needs, and multi-morbidity. Formalized handovers between providers are lacking. This results in information gaps and additional and sometimes unnecessary time spent by healthcare providers searching for care plan documentation.

A third demand is the lack of timely access to respiratory health professionals experienced in HMV and availability of home follow-up, particularly in the early stages of transition which impedes the transition process.

Virtual Care can be defined as any interaction between patients and/or members of their circle of care, occurring remotely, using any form of communication or information technology, with the aim of facilitating or maximizing the effectiveness and quality of patient care. It includes electronic messaging, tele-consultations and tele-monitoring. The advantages of virtual care include the following: 1) enabling the preconditions for truly empowered patients and patient/family-centered care; 2) overcoming the silos of care, and 3) reducing redundancy within the healthcare system by greater knowledge sharing across healthcare sectors. Virtual care provides an opportunity to make healthcare better by overcoming constraints of distance, cost, and time.

In TTLive Study, a multi-component platform delivered on an electronic tablet developed for complex care management at home is used in partnership with the patient, family and healthcare team to enable the following: 1) virtual home visits; 2) customizable care plans; 3) basic clinical workflows that incorporate reminders, completion of symptom profiles and tele-monitoring, and 4) secure communication via messaging, audio, and video calls. Investigators hypothesize that this virtual transition intervention will reduce emergent healthcare utilization, improve the experience of care, reduce caregiver burden, become more cost-effective than usual care, and enable more efficient use of healthcare provider time.

Study Type

Interventional

Enrollment (Actual)

444

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada
        • McMaster Children's Hospital
      • London, Ontario, Canada
        • London Health Sciences Center
      • London, Ontario, Canada, N6A 5W9
        • Children's Hospital, London Health Sciences
      • Ottawa, Ontario, Canada
        • The Ottawa Hospital
      • Ottawa, Ontario, Canada
        • Children's Hospital of Eastern Ontario
      • Toronto, Ontario, Canada, M5G 1X8
        • The Hospital for Sick Children
      • Toronto, Ontario, Canada
        • Sunnybrook Health Sciences Center
      • York, Ontario, Canada, M6M 2J5
        • West Park Healthcare Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Participant Eligibility Criteria

Inclusion Criteria:

i. Individuals newly initiated (in-hospital or as an outpatient) on a ventilator for HMV prescribed by a participating ventilation program in the previous two months.

ii. Reads, writes and understands English if does not have a caregiver than can do so.

iii. Provides informed consent.

Exclusion criteria:

i. Projected life expectancy of ≤ 2 months. ii. Significant cognitive impairment and absence/inability of a family caregiver to use aTouchAway™ or complete questionnaires.

iii. Uncontrolled psychiatric illness. iv. No internet access (SIM cards and data costs will be covered by the project budget).

v. Currently enrolled in a research study to evaluate another eHealth platform or care coordination.

vi. Plans to move outside of Ontario within the next 12 months.

Caregivers Eligibility Criteria

Caregiver Inclusion Criteria:

i. Primary caregiver of an individual newly initiated (in-hospital or outpatient) on a ventilator for HMV prescribed by a participating clinic in the previous two months; ii. Reads, writes and understands English; and iii. Provides informed consent.

Eligibility Criteria for the Qualitative Interviews

Investigators will exclude those participants:

i. Unable to communicate verbally for the duration of an interview

Inclusion Criteria for Healthcare Providers in the Circle of Care for the Intervention Group

Healthcare provider of an individual from a participating centre i. Use of the aTouchAway for at least five participant encounters ii. Provides informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants will receive multi-component Virtual Transition Intervention facilitated through the aTouchAway™ platform including the usual care provided by specialist HMV programs.
Participants will receive multi-component Virtual Transition Intervention. The four components of the intervention comprise: (1) routine virtual clinic visits scheduled at the same frequency as usual care; (2) virtual care plan and action plan for respiratory infection/deterioration and management of ventilator issues; (3) remote, weekly and monthly monitoring of ventilator and cough assist metrics, VAI symptoms, and oxygen saturations; and (4) as needed clinical consultations triggered by identification of abnormal parameters or requested by the VAI or family caregiver.
No Intervention: Control
Usual care will be delivered in accordance with the Canadian Thoracic Society (CTS) clinical practice guidelines and includes scheduled face-to-face clinic visits with the ventilator team with the ventilator team within the first month of starting HMV and then every 3, 6, or 12 months depending on medical stability with additional telephone calls/email contact for equipment trouble shooting and management of intercurrent illnesses as needed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ED Visits: ED visit rates at 12 months determined using health administrative databases
Time Frame: 12 months± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months± 4 weeks
To measure caregiver reported sense of mastery (Pearlin Mastery Scale; scores range up to 28, higher scores = higher mastery), if no caregiver available then patient reported sense of mastery will be utilized
Time Frame: 12 months± 4 weeks
To measure caregiver reported sense of mastery, an outcome that is often linked to patient empowerment using the Pearlin Self-Mastery Scale, if no caregiver available then patient reported sense of mastery will be utilized
12 months± 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of hospital admissions and days in hospital over 6 months using health administrative databases.
Time Frame: 6 months± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months± 4 weeks
Number of hospital admissions and days in hospital over 12 months using health administrative databases.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Hospital free survival using health administrative data at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Hospital free survival using health administrative data at 12 months.
Time Frame: 12 Months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 Months ± 4 weeks
Time to first ED visit and first hospital admission.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Overall survival at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Overall survival at 12 months.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Respiratory and non-respiratory causes of death at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Respiratory and non-respiratory causes of death at 12 months.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Number and type of outpatient specialist visits at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Number and type of outpatient specialist visits at 12 months.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Number of family physician visits at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Number of family physician visits at 12 months.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Homecare service use at 6 months.
Time Frame: 6 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Homecare service use at 12 months.
Time Frame: 12 months ± 4 weeks
Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Change in Zarit Burden Interview Score from baseline to 6 months.The 22 items are assessed on a 5-point Likert scale, ranging from 0 = 'never' to 4 = 'nearly always'.
Time Frame: 6 months ± 4 weeks
Caregiver Outcome
6 months ± 4 weeks
Change in Zarit Burden Interview Score from baseline to 12 months.The 22 items are assessed on a 5-point Likert scale, ranging from 0 = 'never' to 4 = 'nearly always'.
Time Frame: 12 months ± 4 weeks
Caregiver Outcome
12 months ± 4 weeks
Change in study participant health related quality of life using the EQ-5D (adults) and ED-5DY (children) change from baseline and 6 months
Time Frame: 6 months ± 4 weeks
Health Related Quality of Life Outcome
6 months ± 4 weeks
Change in study participant health related quality of life using the EQ-5D (adults) and ED-5DY (children) change from baseline and 12 months
Time Frame: 12 months ± 4 weeks
Health Related Quality of Life Outcome
12 months ± 4 weeks
Quality of care coordination using Family Experiences with Care Coordination (FECC) for qualitative interview participants only
Time Frame: 6 months ± 4 weeks
Care Coordination Outcome
6 months ± 4 weeks
Incremental Cost Effectiveness Ratios (ICER) of Virtual Transition intervention compared to usual care in improving patient utility from a societal perspective and using a one-year time horizon
Time Frame: 12 months ± 4 weeks
Economic Outcome
12 months ± 4 weeks
Mean monthly healthcare costs (public, private and caregiver lost time) over 6 months
Time Frame: 6 months ± 4 weeks
Economic Outcome: Using health administrative databases and the Ambulatory Health Care Record-modified
6 months ± 4 weeks
Mean monthly healthcare costs (public, private and caregiver lost time) over 12 months
Time Frame: 12 months ± 4 weeks
Economic Outcome: Using health administrative databases and the Ambulatory Health Care Record-modified
12 months ± 4 weeks
Encounter time spent by clinicians over 12 months measured using the Care Coordination Measurement Tool
Time Frame: 12 months ± 4 weeks
HealthCare Provider Outcome
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
n(%) of 5 clinic visits conducted virtually as opposed to face to face
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
n (%) of virtual data downloads available for the virtual clinic visits
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
n(%) participants that completed the virtual care plan within 6 weeks after intervention initiation
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
n (%) of the 52 weekly check-ins completed
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
n(%) of the 12 monthly S3-NIV check-ins completed
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
number of ad hoc questions/concerns in which healthcare team contacted via the platform
12 months ± 4 weeks
Process Measure Outcomes
Time Frame: 12 months ± 4 weeks
number of status yellow monitoring alerts initiated based on the weekly and monthly symptom monitoring and time to alert being addressed by a member of the circle of care
12 months ± 4 weeks
Process Measure Outcome- Qualitative Interviews
Time Frame: 6 months ± 4 weeks
Qualitative interviews to explore the experience with the aTouchAway intervention by study participants, caregivers and healthcare providers
6 months ± 4 weeks
Process Measure Outcome- Site focus Groups
Time Frame: 24 months ± 4 weeks

Our LIVE study data has shown reduction in ED visits due to the pandemic and since ED Visits are the primary outcome for TtLIVE, as a process measure, we will conduct a one-time focus group to generate a hierarchy of important study primary and secondary outcomes with participating sites.

Site focus groups: Every participating site will get an opportunity to participate in a 30-60-minute focus group to discuss and rank outcomes relevant to their practice over zoom

24 months ± 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louise Rose, PhD, King's College London
  • Principal Investigator: Reshma Amin, MD, MSc, The Hospital for Sick Children
  • Principal Investigator: Andrea Gershon, MD, MSc, Sunnybrook Health Sciences Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

January 30, 2026

Study Completion (Actual)

January 30, 2026

Study Registration Dates

First Submitted

November 21, 2019

First Submitted That Met QC Criteria

November 25, 2019

First Posted (Actual)

November 27, 2019

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

January 30, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Long-term Ventilation at Home

Clinical Trials on aTouchAway™ platform

Subscribe